Dabur Pharma rechristened 'Fresenius Kabi Oncology' - Business Standard Print

... Stock Exchange (BSE) about this today. The Delhi-based Dabur Pharma was acquired by the Singapore-based Fresenius Kabi for around Rs 1000 crore last year.

read more